{
  "resourceType" : "PlanDefinition",
  "id" : "MethotrexateMonitoringRecommendation",
  "meta" : {
    "profile" : ["http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PlanDefinition</b><a name=\"MethotrexateMonitoringRecommendation\"> </a><a name=\"hcMethotrexateMonitoringRecommendation\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PlanDefinition &quot;MethotrexateMonitoringRecommendation&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/uv/cpg/STU1/StructureDefinition-cpg-recommendationdefinition.html\">CPGRecommendationDefinition</a></p></div><p><b>knowledgeCapability</b>: computable</p><p><b>url</b>: <code>http://example.org/PlanDefinition/MethotrexateMonitoringRecommendation</code></p><p><b>version</b>: 0.1.0</p><p><b>name</b>: MethotrexateMonitoringRecommendation</p><p><b>title</b>: Methotrexate Monitoring Recommendation</p><p><b>type</b>: ECA Rule <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-plan-definition-type.html\">PlanDefinitionType</a>#eca-rule)</span></p><p><b>status</b>: draft</p><p><b>experimental</b>: true</p><p><b>date</b>: 2024-05-17 14:59:55-0400</p><p><b>publisher</b>: Example Publisher</p><p><b>contact</b>: Example Publisher: <a href=\"http://example.org/example-publisher\">http://example.org/example-publisher</a></p><p><b>description</b>: Monitoring tests for antirheumatic drug therapy for Methotrexate.</p><blockquote><p><b>relatedArtifact</b></p><p><b>type</b>: citation</p><p><b>citation</b>: Criswell LA, Saag KG, Sems KM et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database Syst Rev 2000;(2):CD001158 PubMed.</p><p><b>url</b>: <a href=\"https://pubmed.ncbi.nlm.nih.gov/10796420\">https://pubmed.ncbi.nlm.nih.gov/10796420</a></p><blockquote><p><b>document</b></p></blockquote></blockquote><p><b>library</b>: <a href=\"Library-ApplicabilityLogic.html\">ApplicabilityLogic</a></p><blockquote><p><b>action</b></p><p><b>Quality of evidence</b>: High quality <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-evidence-quality.html\">QualityOfEvidenceRating</a>#high)</span></p><p><b>Strength of recommendation</b>: Strong <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-recommendation-strength.html\">StrengthOfRecommendationRating</a>#strong)</span></p><p><b>directionOfRecommendation</b>: For <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/uv/cpg/STU1/CodeSystem-cpg-recommendation-direction.html\">CPG Recommendation Direction</a>#for)</span></p><p><b>title</b>: Order monitoring tests for antirheumatic drug therapy (Methotrexate).</p><p><b>description</b>: Order monitoring tests for antirheumatic drug therapy (Methotrexate).</p><p><b>code</b>: Conduct Diagnostic Tests <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/uv/cpg/STU1/CodeSystem-cpg-common-process.html\">CPG Common Process</a>#diagnostic-testing)</span></p><blockquote><p><b>condition</b></p><p><b>kind</b>: applicability</p><h3>Expressions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Language</b></td><td><b>Expression</b></td></tr><tr><td style=\"display: none\">*</td><td>text/cql-identifier</td><td>Should order CBC if on Methotrexate therapy and missing test</td></tr></table></blockquote><h3>Inputs</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Profile</b></td></tr><tr><td style=\"display: none\">*</td><td>Observation</td><td><a href=\"StructureDefinition-ActiveMethotrexateFeature.html\">Active Methotrexate Feature</a></td></tr><tr><td style=\"display: none\">*</td><td>Observation</td><td><a href=\"StructureDefinition-LastCbcPanelReportDateFeature.html\">Last CBC Panel Report Date Feature</a></td></tr></table><p><b>definition</b>: <a href=\"ActivityDefinition-OrderCBCActivity.html\">Order CBC Activity</a></p></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueCode" : "computable"
  }],
  "url" : "http://example.org/PlanDefinition/MethotrexateMonitoringRecommendation",
  "version" : "0.1.0",
  "name" : "MethotrexateMonitoringRecommendation",
  "title" : "Methotrexate Monitoring Recommendation",
  "type" : {
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code" : "eca-rule"
    }]
  },
  "status" : "draft",
  "experimental" : true,
  "date" : "2024-05-17T14:59:55-04:00",
  "publisher" : "Example Publisher",
  "contact" : [{
    "name" : "Example Publisher",
    "telecom" : [{
      "system" : "url",
      "value" : "http://example.org/example-publisher"
    }]
  }],
  "description" : "Monitoring tests for antirheumatic drug therapy for Methotrexate.",
  "relatedArtifact" : [{
    "type" : "citation",
    "citation" : "Criswell LA, Saag KG, Sems KM et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. Cochrane Database Syst Rev 2000;(2):CD001158 PubMed.",
    "url" : "https://pubmed.ncbi.nlm.nih.gov/10796420",
    "document" : {
      "url" : "https://pubmed.ncbi.nlm.nih.gov/10796420"
    }
  }],
  "library" : ["http://example.org/Library/ApplicabilityLogic"],
  "action" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/cqf-qualityOfEvidence",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/evidence-quality",
          "code" : "high"
        }]
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "http://terminology.hl7.org/CodeSystem/recommendation-strength",
          "code" : "strong"
        }]
      }
    },
    {
      "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-directionOfRecommendation",
      "valueCodeableConcept" : {
        "coding" : [{
          "system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-recommendation-direction",
          "code" : "for"
        }]
      }
    }],
    "title" : "Order monitoring tests for antirheumatic drug therapy (Methotrexate).",
    "description" : "Order monitoring tests for antirheumatic drug therapy (Methotrexate).",
    "code" : [{
      "coding" : [{
        "system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-common-process",
        "code" : "diagnostic-testing"
      }]
    }],
    "condition" : [{
      "kind" : "applicability",
      "expression" : {
        "language" : "text/cql-identifier",
        "expression" : "Should order CBC if on Methotrexate therapy and missing test"
      }
    }],
    "input" : [{
      "type" : "Observation",
      "profile" : ["http://example.org/StructureDefinition/ActiveMethotrexateFeature"]
    },
    {
      "type" : "Observation",
      "profile" : ["http://example.org/StructureDefinition/LastCbcPanelReportDateFeature"]
    }],
    "definitionCanonical" : "http://example.org/ActivityDefinition/OrderCBCActivity"
  }]
}